Glossary

AJAX progress indicator
Search:
(clear)
  • UKECA
    United Kingdom Ethics Committee Authority (UKECA) http://www.hra.nhs.uk/resources/research-legislation-and-governance/four-nations/"
  • United Kingdom Ethics Committee Authority
    United Kingdom Ethics Committee Authority (UKECA) http://www.hra.nhs.uk/resources/research-legislation-and-governance/four-nations/"
  • Universal Declaration of Human Rights
    The Universal Declaration of Human Rights is an international document that states the basic rights and fundamental freedoms to which all human beings are entitled. It was adopted by the General Assembly of the United Nations in 1948, as a result of the experience and atrocities of the Second(...)
  • URPL
    Polish National Competent Authority. http://www.urpl.gov.pl/"
  • Urząd Rejestracji Produktów Leczniczych, Wyrobow Medycznych i Produktów Biobójczych
    Polish National Competent Authority. http://www.urpl.gov.pl/"
  • Utility
    Utility, or usefulness, is the (perceived) ability of something to satisfy needs or wants. In health economics, utilities measure the strength of patient preferences. For example, how important various factors are to patients, such as symptoms, pain, and psychological health. The impact of new(...)
  • Vaccine
    Vaccines are biological preparations developed from modified versions of the micro-organisms that cause a disease. Vaccines improve or convey immunity to particular diseases, usually in an effort to prevent or cure disease.
  • Validity
    Scientific validity refers to how well a measurement, test or study measures what it is intended to measure.
  • Valstybinė vaistų kontrolės tarnyba
    Lithuanian National Competent Authority.http://www.vvkt.lt/"
  • Vector
    In gene therapy, a vector is a method of delivering DNA into patients' cells. A common vector used in gene therapy is the adenovirus. A gene therapy vector must be customised to attempt treatment of a particular disorder. To be successful, a vector must target the right cells, the gene it is(...)
  • Vulnerable participants or populations
    Vulnerable participants or populations are individuals or groups of individuals who are unable to give informed consent to take part in a clinical trial, such as children or people affected by mental health conditions, or who may come under pressure from others to take part. It also includes(...)
  • VVKT
    Lithuanian National Competent Authority.http://www.vvkt.lt/"
  • Wash out period
    In a clinical trial, this refers to a break in ongoing treatment. It is quite often used in crossover trials where a set period is defined before switching to a new medicine. In this period the levels of the previous medicine in the body and the effects should be reduced to zero.

Find Out More